Bollywood couple Riteish and Genelia Deshmukh invest in Homeopathy startup

Rate this post, global homeopathy treatment power brand announces that it has raised an undisclosed round of funding from Bollywood power couple Riteish & Genelia Deshmukh along with Mr. LC Singh, Ex- Senior VP of TCS & currently the Vice-Chairman & CEO of Nihilent Technologies. With this current raise, the company aims to further raise a total sum of US$ 5 million. Since its launch, has extended its reach across the world with patients in over 36 countries and conducts over 4500+ consultations per day.

Speaking about his association with, Bollywood actor Riteish Deshmukh said, “I am glad to be a part of’s growth, my wife and I strongly believe in homeopathic solutions and implement them in our family. Being a part of the family in terms of a business and the brand was an easy decision for Genelia and me. We hope that our association with the brand helps its further growth.”

Bollywood couple, Reteish Deshmukh, Genelia Deshmukh, Homeopathy startup Welcomecure

Punit Desai, Co-founder & CEO of said, “It is wonderful to see the growing adoption and success of homeopathy on a global level. It is safe to say that has grown exponentially with the growth of the sector, and its success can be attributed to our unique offering, where we bring the best caregivers and experts in homeopathic medicine across the globe under one roof for our patients. With their contribution in this this round, Bollywood power-couple Riteish & Genelia Deshmukh will also endorse the service as they become the brand ambassadors of the health-tech platform. The couple’s belief in this form of medicine and their efforts towards expanding awareness regarding our brand and the space will help extend our services to more patients in need. We hope that the growth of and the industry will result in benefiting patients all over the world.”

Following its beta launch in November 2014 by founders Dr. Jawahar Shah, Punit Desai & Nidhi Desai, the portal commercially launched a year later in January 2016. Within 18 months of commercial launch the health-tech platform turned profitable and is now eyeing a herculean share in the global natural and alternative medicine market. The business has grown over 450% last year and been EBIDTA positive. Current fiscal the business envisages Rs.50 crore upwards of top line.

This Post Has One Comment

Leave a Reply